We are live on ! Find out more
DADC

D.A. Davidson & Co Portfolio holdings

AUM $18.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+2.55%
1 Year Est. Return
+24.63%
3 Year Est. Return
+70.71%
5 Year Est. Return
+77.77%
10 Year Est. Return
+255.18%
AUM
$4.43B
AUM Growth
+$304M
Cap. Flow
+$215M
Cap. Flow %
4.85%
Top 10 Hldgs %
28.31%
Holding
2,533
New
165
Increased
888
Reduced
729
Closed
137

Top Sells

Rank Stock Value
1
KRC icon
Kilroy Realty
KRC
+$14.6M
2
ABBV icon
AbbVie
ABBV
+$7.15M
3
CAG icon
Conagra Brands
CAG
+$6.73M
4
KBR icon
KBR
KBR
+$4.75M
5
DE icon
Deere & Co
DE
+$4.43M

Sector Composition

Rank Sector Weight
1 Healthcare 9.11%
2 Technology 8.74%
3 Industrials 8.05%
4 Financials 7.99%
5 Consumer Discretionary 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTRS icon
726
Northern Trust
NTRS
$22.2B
$356K 0.01%
3,670
+148
+4% +$13.3K
RMT
727
Royce Micro-Cap Trust
RMT
$736M
$356K 0.01%
41,246
+7,280
+21% +$62.5K
THS
728
DELISTED
Treehouse Foods
THS
$353K 0.01%
4,323
-1,746
-29% -$143K
ANSS
729
DELISTED
Ansys
ANSS
$351K 0.01%
2,887
-281
-9% -$33.1K
HRL icon
730
Hormel Foods
HRL
$13.9B
$348K 0.01%
10,227
+610
+6% +$21K
VCIT icon
731
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$348K 0.01%
3,979
-296
-7% -$25.8K
WTM icon
732
White Mountains Insurance
WTM
$5.47B
$348K 0.01%
401
-1
-0.2% -$868
UHS icon
733
Universal Health Services
UHS
$9.43B
$346K 0.01%
2,838
+66
+2% +$7.86K
IBMK
734
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
$345K 0.01%
13,290
+500
+4% +$13K
EGRX
735
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$343K 0.01%
4,350
+100
+2% +$8.18K
OUT icon
736
Outfront Media
OUT
$5.64B
$342K 0.01%
15,029
-771
-5% -$18.3K
POST icon
737
Post Holdings
POST
$4.12B
$341K 0.01%
6,723
-459
-6% -$24.7K
XBI icon
738
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$341K 0.01%
4,430
+1,000
+29% +$70.9K
NEWR
739
DELISTED
New Relic, Inc.
NEWR
$340K 0.01%
7,907
+142
+2% +$5.91K
EQT icon
740
EQT Corp
EQT
$33.2B
$339K 0.01%
10,656
+1,324
+14% +$41.9K
FNCL icon
741
Fidelity MSCI Financials Index ETF
FNCL
$2.35B
$339K 0.01%
9,352
+512
+6% +$18K
GRFS
742
Grifois
GRFS
$5.16B
$339K 0.01%
16,075
+2,022
+14% +$42.4K
WBS icon
743
Webster Financial
WBS
$12.3B
$336K 0.01%
6,443
+559
+10% +$28.2K
CXT icon
744
Crane NXT
CXT
$3.04B
$335K 0.01%
12,158
+1,319
+12% +$35.7K
MCHP icon
745
Microchip Technology
MCHP
$42.8B
$333K 0.01%
8,654
-470
-5% -$18.5K
CIM
746
Chimera Investment
CIM
$1.05B
$332K 0.01%
5,946
+605
+11% +$35K
PI icon
747
Impinj
PI
$3.89B
$331K 0.01%
6,804
+6,504
+2,168% +$273K
PPL
748
PPL Corp
PPL
$27.3B
$330K 0.01%
8,554
+344
+4% +$13.3K
EEFT icon
749
Euronet Worldwide
EEFT
$3.02B
$329K 0.01%
3,768
+791
+27% +$67.8K
EMO
750
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.06B
$329K 0.01%
5,162
+903
+21% +$59K

Similar funds

D.A. Davidson & Co's Q2 2017 Portfolio in Review

As of Q2 2017, D.A. Davidson & Co held 2,533 positions worth $4.43B, up 7.4% from $4.12B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

D.A. Davidson & Co deployed $215M of net new capital in Q2 2017, opening 165 new positions and adding to 888 existing holdings. Its largest new stake was AutoZone: 2,429 shares worth $1.39M.

By sector, the portfolio is most concentrated in Healthcare at 9.1% of assets, up from 9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AbbVie, an estimated $7.15M trimmed.

  • D.A. Davidson & Co's largest Q2 2017 buy was AutoZone: 2,429 shares worth $1.39M.
  • D.A. Davidson & Co added most to Vanguard Value ETF in Q2 2017, an estimated $20.9M increase.
  • D.A. Davidson & Co's biggest Q2 2017 reduction was AbbVie, cutting an estimated $7.15M.
  • D.A. Davidson & Co fully exited Kilroy Realty in Q2 2017, selling an estimated $14.6M.
  • D.A. Davidson & Co's ten largest holdings make up 28% of its $4.43B portfolio in Q2 2017.
  • D.A. Davidson & Co opened 165 new positions and closed 137 in Q2 2017.
  • D.A. Davidson & Co's portfolio value rose 7.4% quarter-over-quarter to $4.43B.

Based on D.A. Davidson & Co's 13F filing for Q2 2017, filed 11 Aug 2017.